Longwood Fund

Funding rounds backed by Longwood Fund.

Export CSV
Funding disclosed in full
$263M
Median round
$76M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Khartis Therapeutics

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries BBiotechUnited States
6 participantsAlexandria Venture InvestmentsForesite CapitalForge Life Science PartnersLilly Asia VenturesLongwood FundNextech Invest
Sidewinder Therapeutics

Develops next-generation bispecific ADCs for cancer treatment

$137MSeries BBiotechUnited States
9 participantsAlexandria Real Estate EquitiesAstellas Venture ManagementDCVC BioFrazier Life SciencesGoldman Sachs Alternatives Life SciencesLongwood FundNovartis Venture FundOrbiMedSamsara BioCapital
Mediar Therapeutics

Develops therapies to halt fibrosis in multiple organ systems

$76MSeries BBiotechUnited States
5 participantsAlexandria Real Estate Trust (ARE)Amplitude VenturesAsahi Kasei Pharma VenturesICGLongwood Fund